The regulatory landscape for artificial intelligence (AI) is shaping up on both sides of the Atlantic, urgently awaited by the scientific and industrial community. Commonalities and differences start to crystallize in the approaches to AI in medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Approved trends and product characteristics of digital therapeutics in four countries
npj Digital Medicine Open Access 26 May 2025
-
Elevating Developers’ Accountability Awareness in AI Systems Development
Business & Information Systems Engineering Open Access 05 January 2025
-
Survey evidence on public support for AI safety oversight
Scientific Reports Open Access 28 December 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan (FDA, 2021).
Executive Office of the President: Guidance for Regulation of Artificial Intelligence Applications (The White House, 2020).
Proposal for a Regulation Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) (European Commission, 2021).
Vokinger, K. N., Feuerriegel, S. & Kesselheim, A. S. Lancet Digit. Health 3, 337–338 (2021).
Oren, O., Gersh, B. J. & Bhatt, D. L. Lancet Digit. Health 2, 486–488 (2020).
Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) (FDA, 2019).
Lavizzo-Mourey, R. J., Besser, R. E. & Williams, D. R. NEJM 18, 1681–1684 (2021).
Canto, J. G., Rogers, W. & Goldberg, R. J. JAMA 8, 813–822 (2012).
Parikh, R. B., Teeple, S. & Navathe, A. S. JAMA 322, 2377 (2019).
Kausha, A., Altman, R. & Langlotz, C. JAMA 324, 1212 (2020).
Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Lancet Digit. Health 3, 195–203 (2021).
Rajkomar, A. et al. NPJ Digital Med. 1, 18 (2018).
Toscano, F., O’Donnell, E. & Unruh, M. et al. Eur. J. Publ. Health 28, cky213.401 (2018).
Die elektronische Patientenakte (Bundesministerium für Gesundheit, accessed 13 June 2021); https://www.bundesgesundheitsministerium.de/elektronische-patientenakte.html
Acknowledgements
This study was partially funded by the Swiss National Science Foundation (SNSF).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vokinger, K.N., Gasser, U. Regulating AI in medicine in the United States and Europe. Nat Mach Intell 3, 738–739 (2021). https://doi.org/10.1038/s42256-021-00386-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s42256-021-00386-z
This article is cited by
-
Approved trends and product characteristics of digital therapeutics in four countries
npj Digital Medicine (2025)
-
Elevating Developers’ Accountability Awareness in AI Systems Development
Business & Information Systems Engineering (2025)
-
The implications of artificial intelligence in clinical healthcare: a scoping review on regulatory challenges up to 2023
Health and Technology (2025)
-
Survey evidence on public support for AI safety oversight
Scientific Reports (2024)
-
Multicenter PET image harmonization using generative adversarial networks
European Journal of Nuclear Medicine and Molecular Imaging (2024)